We analyzed the expression of the 4 FGFRs and the dominant cancer-associated ligand (FGF-2/basic FGF) at the mRNA level in a panel of 30 UC cell lines by whole genome expression profiling (Illumina platform). The gene discussed is FGF2; the disease is cancer.